Simplex Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-132
| Closed | -$56 | – | 10624 |
|
|
2022
Q4 | $0 | Sell |
132
-184
| -58% | -$60 | ﹤0.01% | 10935 |
|
|
2022
Q3 | $0 | Buy |
316
+279
| +754% | +$96 | ﹤0.01% | 11300 |
|
|
2022
Q2 | $0 | Sell |
37
-26,875
| -100% | -$11.1K | ﹤0.01% | 11554 |
|
|
2022
Q1 | $18K | Buy |
26,912
+15,997
| +147% | +$13.6K | ﹤0.01% | 8383 |
|
|
2021
Q4 | $14K | Sell |
10,915
-21,321
| -66% | -$37.8K | ﹤0.01% | 8781 |
|
|
2021
Q3 | $87K | Hold |
32,236
| – | – | ﹤0.01% | 6820 |
|
|
2021
Q2 | $88K | Buy |
32,236
+11,972
| +59% | +$29.8K | ﹤0.01% | 6921 |
|
|
2021
Q1 | $52K | Sell |
20,264
-17,599
| -46% | -$49.8K | ﹤0.01% | 6583 |
|
|
2020
Q4 | $105K | Sell |
37,863
-10,381
| -22% | -$30.2K | ﹤0.01% | 5401 |
|
|
2020
Q3 | $222K | Buy |
48,244
+40,657
| +536% | +$134K | ﹤0.01% | 3973 |
|
|
2020
Q2 | $21K | Sell |
7,587
-2,420
| -24% | -$7.76K | ﹤0.01% | 6202 |
|
|
2020
Q1 | $24K | Sell |
10,007
-22,123
| -69% | -$79.9K | ﹤0.01% | 5811 |
|
|
2019
Q4 | $164K | Sell |
32,130
-32,917
| -51% | -$183K | ﹤0.01% | 3972 |
|
|
2019
Q3 | $420K | Buy |
+65,047
| New | +$449K | ﹤0.01% | 2790 |
|
|
2019
Q2 | – | Sell |
-1,882
| Closed | -$14.3K | – | 8042 |
|
|
2019
Q1 | $20K | Buy |
1,882
+499
| +36% | +$4.97K | ﹤0.01% | 5734 |
|
|
2018
Q4 | $11K | Sell |
1,383
-121
| -8% | -$1.75K | ﹤0.01% | 5805 |
|
|
2018
Q3 | $29K | Sell |
1,504
-6,787
| -82% | -$124K | ﹤0.01% | 5681 |
|
|
2018
Q2 | $149K | Buy |
8,291
+6,855
| +477% | +$101K | ﹤0.01% | 3825 |
|
|
2018
Q1 | $15K | Sell |
1,436
-989
| -41% | -$15.9K | ﹤0.01% | 3659 |
|
|
2017
Q4 | $102K | Buy |
2,425
+1,102
| +83% | +$49.4K | ﹤0.01% | 1790 |
|
|
2017
Q3 | $72K | Sell |
1,323
-2,715
| -67% | -$458K | ﹤0.01% | 1986 |
|
|
2017
Q2 | $749K | Sell |
4,038
-405
| -9% | -$71K | 0.03% | 473 |
|
|
2017
Q1 | $531K | Buy |
4,443
+2,274
| +105% | +$238K | 0.02% | 645 |
|
|
2016
Q4 | $215K | Buy |
+2,169
| New | +$228K | 0.01% | 1006 |
|
|
2015
Q4 | – | Sell |
-1,225
| Closed | -$159K | – | 6350 |
|
|
2015
Q3 | $126K | Buy |
+1,225
| New | +$144K | 0.01% | 1236 |
|
Other funds holding SIOX
JC
CIA
BBA
Simplex Trading's SIOX Position: Q1 2023 in Review
Simplex Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 132 shares — an estimated $56 sold.
Simplex Trading first reported a position in SIOX in Q3 2015 and held it in 25 quarters. The position peaked at $749K in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.
- Simplex Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 132 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $56.
- Simplex Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 25 quarters.
- Simplex Trading's Sio Gene Therapies Inc. Common Stock position peaked at $749K in Q2 2017.
- 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.